Nicolas Warin
Inventor
Stats
- 0 US patents issued
- 6 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 0 US Patents Issued
- 6 US Applications Filed
- 0 Total Citation Count
- Jun 23, 2022 Most Recent Filing
- Dec 17, 2020 Earliest Filing
Work History
No Work History Available.Inventor Addresses
| Address | Duration |
|---|---|
| Basel, CH | Nov 17, 22 - Nov 07, 24 |
| Blotzheim, FR | Dec 22, 22 - Feb 18, 25 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 4 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 3 |
| C07D: | HETEROCYCLIC COMPOUNDS | 4 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 12226405 | 2025 | Compounds and compositions for inhibiting the activity of HIF2-alpha and their methods of use | 0 |
| 2024/0366,567 | 2024 | PHARMACEUTICAL COMBINATIONS COMPRISING A KRAS G12C INHIBITOR AND USES THEREOF FOR THE TREATMENT OF CANCERS | 0 |
| 2024/0317,721 | 2024 | PYRAZOLYL DERIVATIVES AS INHIBITORS OF THE KRAS MUTANT PROTEIN | 0 |
| 2024/0116,900 | 2024 | NEW CRYSTALLINE FORMS OF A KRAS G12C INHIBITOR COMPOUND | 0 |
| 2024/0082,218 | 2024 | PHARMACEUTICAL COMBINATIONS COMPRISING A KRAS G12C INHIBITOR AND USES OF A KRAS G12C INHIBITOR FOR THE TREATMENT OF CANCERS | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.